Navigation Links
GIBCO Improved MEM Zn++ Option (Richter's Modification) liquid from Invitrogen

ProductsGIBCO Improved MEM Zn++ Option (Richter's Modification) liquid from Invitrogen
Company Invitrogen
Item GIBCO Improved MEM Zn++ Option (Richter's Modification) liquid
Price 
Description Request Info
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GIBCO Dulbeccos Modified Eagle Medium (D-MEM); powder (high glucose) from Invitrogen
2. GIBCO CD 293 AGT from Invitrogen
3. GIBCO Iscoves Modified Dulbeccos Medium (IMDM); powder from Invitrogen
4. GIBCO RPMI Medium 1640; powder from Invitrogen
5. GIBCO AmnioMAX-C100 Basal Medium liquid from Invitrogen
6. GIBCO RPMI Medium 1640; powder from Invitrogen
7. GIBCO Earles Balanced Salt Solution (EBSS) (1X); liquid from Invitrogen
8. GIBCO Bovine Serum from Invitrogen
9. GIBCO Graces Insect Cell Culture Medium; powder from Invitrogen
10. GIBCO Newborn Calf Serum from Invitrogen
11. GIBCO Sf-900 II SFM (1X) liquid from Invitrogen
Rabbit Anti-Schizosaccharomyces pombe SpUlp2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human STX18 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Human sRANKL Polyclonal Antibody, Biotin Conjugated from Cell Sciences
Mouse Anti-CD42d Monoclonal Antibody, Unconjugated, Clone CLB-SW16 (formerly 708) from Abcam
Biology Products:
(Date:11/23/2009)...ciated strain of the deadly superbug MRSAan infect...bioticsposes a far greater health threat than prev... according to a study in the December issue of Em...s easily picked up in fitness centers, schools, an...l burden of MRSA within hospitals, the report foun...
(Date:11/23/2009)...gests that a common oral bacterium may exacerbate ... et al, "Unique Lipids from a Common Human Bacteri...f Enhancing Autoimmunity," appears in the December.... , Multiple sclerosis (MS), a disease where the...affects nearly 1 in 700 people in the United State...
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 1Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 2Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 3Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 4Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 5Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 7Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 8Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 9Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 10Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 11Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 12Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 13Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 14Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 15Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 16Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 17Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 18Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 19Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 20Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 21Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 22Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 23
...veling the complex mechanisms in the brain that re...etites are controlled by systems very similar to t...type of neuron that is essential for feeding behav... and undergo rapid weight loss. , Remarkably, th...only influenced eating behavior when they were rem...
...des insight into genetic basis of human diseaseHig...lds a map of genetic variation which can give clue...he current technologies collect genotypes, or info...t many scientists believe that drilling down to th... of each chromosome -- so-called haplotypes -- wil...
...he last ice age are the likely culprits in the ext...rican great mammals such as mammoths, mastodons an...da researcher. , Determining whether the first arr...inent at the end of the last Ice Age was responsib...d scientists because both events occurred at the s...
Other Biology News:An essential regulator of body weight revealed 2An essential regulator of body weight revealed 3An essential regulator of body weight revealed 4California computer scientists double volume of data in NIH biotech repository 2California computer scientists double volume of data in NIH biotech repository 3California computer scientists double volume of data in NIH biotech repository 4Study shows big game hunters, not climate change, killed off sloths 2Study shows big game hunters, not climate change, killed off sloths 3
(Date:11/24/2009)...dBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--Do...ssetsofHylandSeeds,adivisionofThompsonsLimitedofBl...expandDowAgroSciences,currentseedsbusinessasthecom... 2010 andDowAgroSciencesHerbicideTolerantTraitTec...dinthenearfuture. ,, "Thisacquisitionbringstoge...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.ann...wedthepatentapplicationfor,itsnano-particleoraldel...yefficientapproachtoincorporatepeptidesor,proteins...ofdrugs,otherwiseadministeredasinjections.NODtechn...acromoleculardrugssuchasinsulin,interferon,growth...
(Date:11/24/2009)...ficacyendpointhasbeenmetforpatientswithadvanced-st...Y,Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc....armaceuticalcompanyfocusedonendocrinetherapyandonc...2studywithitstargetedcytotoxicpeptideconjugate,AEZ...rrentendometrialcancer.Inapersonalizedhealthcareap...
(Date:11/24/2009)...ly,November24/PRNewswire/--HealthRoboticstodayanno...groupofselected,investors.ThisrecentlyformedToront...csCanada,Inc.andwillmarket,install,andsupport,Heal...sthe,revolutionaryproductofferingsi.v.STATION(TM),...illalsoprovideassistanceonan"asneeded,basis"toitss...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2